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Patients suffering from various neurological and psychiatric disorders show different lev-
els of facial emotion recognition (FER) impairment, sometimes from the early phases of
the disease. Investigating the relative severity of deﬁcits in FER across different clinical
and high-risk populations has potential implications for the diagnosis and treatment of
these diseases, and could also allow us to understand the neurobiological mechanisms of
emotion perception itself. To investigate the role of the dopaminergic system and of the
frontotemporal network in FER, we reanalyzed and compared data from four of our pre-
vious studies investigating FER performance in patients with frontotemporal dysfunctions
and/or dopaminergic system abnormalities at different stages.The performance of patients
was compared to the performance obtained by a speciﬁc group of matched healthy con-
trols using Cohen’s d effect size. We thus compared emotion and gender recognition in
patients with frontotemporal dementia (FTD), amnestic mild cognitive impairment (aMCI),
Alzheimer’sdisease(AD)atthemilddementiastage,majordepressivedisorder,Parkinson’s
disease treated by l-DOPA (PD-ON) or not (PD-OFF), remitted schizophrenia (SCZ-rem),
ﬁrst-episode schizophrenia treated by antipsychotic medication (SCZ-ON), and drug-naïve
ﬁrst-episode schizophrenia (SCZ-OFF), as well as in unaffected siblings of patients with
schizophrenia (SIB).The analyses revealed a pattern of differential impairment of emotion
(but not gender) recognition across pathological conditions. On the one hand, dopaminer-
gic medication seems not to modify the moderate deﬁcits observed in SCZ and PD groups
(ON vs. OFF), suggesting that the deﬁcit is independent from the dopaminergic system.
On the other hand, the observed increase in effect size of the deﬁcit among the aMCI, AD,
and FTD groups (and also among the SIB and SCZ-rem groups) suggests that the deﬁcit is
dependent on neurodegeneration of the frontotemporal neural networks. Our transnoso-
graphicapproachcombiningclinicalandhigh-riskpopulationswiththeimpactofmedication
provides new information on the trajectory of impaired emotion perception in neuropsy-
chiatric conditions, and on the role of the dopaminergic system and the frontotemporal
network in emotion perception.
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INTRODUCTION
Emotions play a central role in decision-making and adaptation
in humans. Dysfunction of the emotional regulation system is
involved in behavioral and pathological issues, including aggres-
siveness,addiction,andrisk-takingbehavior,aswellasanxietyand
depression (Davidson et al., 2000; Dalgleish, 2004). Among social
cognitive functions, emotion perception has attracted increasing
interest over the last two decades. Emotional stimuli affect basic
and cognitive operations such as perception, attention and mem-
ory,and altered emotion perception is associated with a variety of
neurologicalandpsychiatricconditions(PhillipsandDavid,2003;
Kohler et al., 2004).
THE NEURAL BASES OF THE RECOGNITION OF FACIAL EXPRESSION
Frontotemporal networks
Neuroimaging studies have provided crucial information regard-
ing the neural processes of emotion recognition by showing that
the frontotemporal brain networks are involved in the process-
ing of faces and facial expressions (Haxby et al., 2000; Kanwisher
and Moskovitch, 2000; Eimer and Holmes, 2007). Accordingly,
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a decrease in the ability to recognize facial expressions has been
reported in patients with frontotemporal dementia (FTD, Keane
et al., 2002; Rosen et al., 2004) and has been linked to the trans-
formation from the amnesic mild cognitive impairment (aMCI)
stage toward the dementia stage of Alzheimer’s disease (AD, Spo-
letini et al., 2008; Bediou et al., 2009a). This transformation is
associated with wider frontotemporal lesions (Braak and Braak,
1991). The deﬁcit has also been reported in Williams syndrome,a
rare genetic disorder with disrupted brain networks involving the
frontal and temporal cortex (Isaac and Lincoln, 2011). Impaired
emotion recognition in patients with schizophrenia and their sib-
lings is associated with disturbed brain activity in frontotemporal
networks (Streit et al., 2001; Ioannides et al., 2004; Bediou et al.,
2007b; Seiferth et al., 2008). Finally, the deﬁcit is also present in
patients with major depressive disorder (MDD; Feinberg et al.,
1986;Gur et al.,1992;Rubinow and Post,1992;Persad and Polivy,
1993;however ,seeBediouetal.,2007aforanullresult;forarecent
review of emotion recognition in MDD, see Bediou et al., 2009b),
where it is associated with abnormal activity in frontotemporal
regions (Sheline et al., 2001; Fu et al., 2004, 2007; Lawrence et al.,
2004; Canli et al.,2005; Chan et al.,2009).
Dopamine
Emotionrecognitionhasalsobeenlinkedtothedopaminergicsys-
tem(Delaveauetal.,2005;Salgado-Pinedaetal.,2005).Adecrease
in the ability to recognize facial expressions has been associated
with diseases that are closely linked to dopaminergic dysfunctions
such as Parkinson’s disease (PD, Dujardin et al., 2004; Lachenal-
Chevallet et al.,2006; Lawrence et al.,2007; Clark et al.,2008) and
schizophrenia (SCZ, Zuroff and Colussy, 1986; Heimberg et al.,
1992;LewisandGarver,1995;Wolweretal.,1996;Streitetal.,1997;
Bediou et al., 2005a, 2007a). The deﬁcit has also been observed in
subjects with a heightened risk for schizophrenia (Poreh et al.,
1994; Toomey and Schuldberg, 1995; Mikhailova et al., 1996; Van
‘T Wout et al., 2004; Bediou et al., 2007a) as well as in other clin-
ical and non-clinical samples of high-risk individuals (e.g., those
with social anxiety, schizotypal personality disorder, see Heuer
et al., 2010; Germine and Hooker, 2011), who exhibit abnormal
dopamine transmission (Tost et al.,2010).
Clinical studies
Although impaired facial expression processing had already been
extensivelyreportedinFTD(Lavenuetal.,1999;Keaneetal.,2002;
Rosenetal.,2004)andinschizophrenia(ZuroffandColussy,1986;
Heimbergetal.,1992;Wolweretal.,1996;forareview,seeMandal
et al., 1998), the results are far less consistent in subjects who are
at risk for schizophrenia (Bolte and Poustka, 2003;f o rar e v i e w ,
see Phillips and Seidman,2008),inAD (Cadieux and Greve,1997;
Roudier et al., 1998; Bucks and Radford, 2004), in MDD (for a
review, see Bediou et al., 2009b), in mild cognitive impairment
(Spoletini et al., 2008), in prodromal ALZ (Kohler et al., 2005),
and in PD (Assogna et al.,2008).
To the best of our knowledge, the relative extent of emotion
recognition deﬁcits across different clinical groups has not yet
been investigated. This dearth is partly due to the heterogeneity
of the methods used to investigate the same function in previous
research.Mostof thestudiesonemotionperceptionhaveemerged
from different groups using very different stimuli and paradigms
in different normal and/or clinical populations. Moreover, when
used, control tasks have been another source of methodological
variation across studies. Consequently, it has remained difﬁcult
to address the relative extent of the impairments in emotion
recognition across different pathologies.
THE PRESENT STUDY
Inaseriesof studiesusingthesamestimuliandparadigm(Bediou
et al., 2005a,b, 2007a, 2009a; Lachenal-Chevallet et al., 2006), we
have investigated facial expression recognition in various neu-
rological and psychiatric conditions including SCZ, MDD, PD,
AD, and FTD. In addition, facial expression recognition has been
studied in non-clinical populations such as unaffected siblings
of schizophrenics (SIB) and subjects with aMCI. In each study,
the performance of the studied group was compared to that of a
group of healthy subjects of comparable sex ratio,age,and educa-
tionallevel.Inallstudies,genderrecognitionwasusedasacontrol
task in order to compare the processing of socially signiﬁcant
changeable facial features to that of a more physically invariant
facial feature. These studies have shown that a deﬁcit in emotion
but not in gender recognition was observed in several conditions.
Using the same protocol in multiple neurological and psychiatric
groups provides a unique opportunity to compare these popu-
lations with regard to their ability to recognize facial expression.
We used a statistical method based on the comparison of effect
sizes using Cohen’s d coefﬁcient to compare emotion recognition
performances among these neuropsychiatric diseases that lead to
early social behavior disturbances with those observed in their
matched control groups. The strengths of our method reside in
the use of morphed faces, which increases the sensitivity of the
measurements for both the emotion and the gender recognition
tasks.
Extensive and sometimes inconsistent literature has tried to
link emotion-speciﬁc deﬁcits in patients with anomalies in cir-
cumscribedneuralsystems.Amongthemostfamousexamplesare
the relationships between (a) fear and the amygdala (e.g.,Adolphs
etal.,1994;Krolak-Salmonetal.,2004)andthe(b)putamen/insula
and disgust (e.g., Calder et al., 2000; Krolak-Salmon et al., 2003).
The amygdala and the insula/basal ganglia are affected in various
neurological and psychiatric conditions, including schizophrenia
and obsessive–compulsive disorder, where these brain anomalies
may contribute to impaired face–emotion processing (for a more
thorough discussion, see Sprengelmeyer et al., 1997; Aleman and
Kahn, 2005; Shayegan and Stahl, 2005; Van Rijn et al., 2005).
Importantly, however, differential or emotion-speciﬁc impair-
ments may not necessarily reﬂect speciﬁc neural anomalies and
may arise from differences in low-level properties of the stim-
uli (e.g., Calder et al., 2001; Deruelle and Fagot, 2005)o rf r o m
attentional or cognitive deﬁcits (Adolphs et al.,2005).
Importantly,the goal of the present study was NOT to describe
emotion-speciﬁc recognition deﬁcits in particular populations in
detail. Instead,our aim here was to compare,for the ﬁrst time,the
extentoftheoverallemotionrecognitiondeﬁcitsacrossthevarious
clinicalandhigh-riskpopulationsthatweretestedinourprevious
studies.Toincreasethepowerofourstatisticalanalysis,wefocused
on overall emotion and gender recognition performance (i.e.,
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collapsed across all emotions/genders and all morphing levels).
We did not analyze each emotion or morphing level separately as
this may have resulted in low statistical power. Moreover, detailed
information about the emotions affected in each population can
be found in the relevant literature. In the present study, we focus
on the comparison of overall emotion recognition abilities across
clinical and high-risk populations.
Such a transnosographic investigation of emotion perception
across different clinical and high-risk populations is an important
challenge that has potential implications not only for the pre-
vention, diagnosis, and treatment of these diseases but also for
our understanding of the neurobiological mechanisms of emo-
tion perception itself. On a neurobiological level, understanding
the relationship between impaired emotion perception and the
severity of a disorder may help elucidate the neural networks or
neurotransmitter activity involved in either the disorder or the
mechanisms of emotion perception per se. First, examining emo-
tion recognition in aMCI and mild AD may clarify the impact
of neurodegenerative processes in particular neural structures
especially the amygdala, which is critical for emotion perception
(Adolphs et al., 1994). Second, studying emotion perception abil-
ities in SCZ and PD and assessing the impact of medication may
elucidate the links between emotion recognition and dopaminer-
gic neurotransmission (Salgado-Pineda et al., 2005) and the role
of the mesocorticolimbic and nigrostriatal circuits that are differ-
entially affected by these pathologies (Deutch, 1993). Third, on a
clinicallevel,discoveringatrajectoryof impairedemotionpercep-
tionmayhelpinearlydifferentialdiagnosisandassistintreatment
planning,potentiallyincludingearlyinterventionandprevention.
For example, emotion recognition abilities may help to differen-
tiate between atypical depression, schizophrenia, and subjects at
risk and to detect the conversion from aMCI or prodromal AD
to dementia states, which are critical to planning an appropriate
intervention.
MATERIALS AND METHODS
SUBJECTS
The participants involved in the present study included patients
with schizophrenia in remission (SCZ-rem, N =29); patients
experiencing their ﬁrst-episode, in either the drug-naïve state
(SCZ-ON,N =40) or after they had taken medication (SCZ-OFF,
N =40); unaffected siblings of schizophrenia patients (N =30);
patients with MDD (N =20); PD patients ON (PD-ON, N =12)
or OFF (PD-OFF,N =13) l-DOPA treatment; patients with mild
AD (N =10); patients with FTD (N =10); and patients with
aMCI (N =10). Patients were recruited at the psychiatric depart-
mentatLeVinatierhospitalandattheneurologicaldepartmentat
Hospital Pierre Wertheimer in Lyon (France). First-episode SCZ
patients and their unaffected siblings (SIB) were recruited at the
Ibn Naﬁs Psychiatric Hospital in Marrakech (Morocco). Healthy
controls were recruited from the general population. Diagnoses
were based on respective consensual criteria at the time of assess-
ment. SCZ and MDD patients were diagnosed according to the
Diagnostic and Statistical Manual (DSM) of Mental Disorders
IV criteria (American Psychiatric Association, 1994); idiopathic
PD was diagnosed according to the criteria of the United King-
dom PD brain bank (Gibb and Lees, 1989). Other patients were
diagnosed with the appropriate consensus criteria for an aMCI
(Petersen et al., 1999), mild dementia related to AD (McKhann
et al., 1984), and FTD (Neary et al., 1998). The age and gender
repartition of the patients as well as of their respective control
groupsintheoriginalstudiesarepresentedinTable 1.Importantly,
in each study, there was no difference in age or gender repartition
between the clinical and the control groups. In addition, partic-
ipants in each study completed a series of behavioral measures
and questionnaires as well as a battery of cognitive tests. However,
we did not collect the same information in all groups and only
focused on measures that were relevant to the studied population.
Whenavailable,informationaboutdiseaseonsetanddurationand
participants’descriptions including behavioral and clinical evalu-
ations and questionnaires are provided in these speciﬁc previous
studies (see Table 1).We did not exclude any participant from any
study. There was no clear outlier; thus, all participants from all
studies were included in this reanalysis.
TASKS
Two different tasks were performed: a facial expression recogni-
tion task and a gender recognition task. The order of the tasks was
counterbalancedacrossparticipantsineachgroup.Bothtaskswere
performed using morphed faces varying in terms of the intensity
Table 1 |The ages and gender of participants in each study.
Bediou et al. (2005b) Bediou et al. (2007b) Lachenal-Chevallet
et al. (2006)
Bediou et al. (2009a)
MDD
(N =20)
SCZ-rem
(N =29)
CTL
(N =20)
SCZ-
ON/OFF
(N =40)
SIB
(N =30)
CTL
(N =26)
PD-
OFF/ON
(N =12)
CTL
(N =14)
AD
(N =10)
FTD
(N =10)
aMCI
(N =10)
CTL
(N =10)
Age
(years)
39 (10) 35 (10) 26 (9) 27 (6) 31 (11) 24 (3) 61 (7) 58 (8) 72 (9) 67 (7) 73 (9) 70 (6)
Gender
(M/F)
13/7 16/13 13/7 40/0 30/0 26/0 10/2 8/6 5/5 5/5 5/5 5/5
MDD,majordepressivedisorder;SCZ-rem,remittedschizophrenia;SCZ-ON/OFF ,haloperidol;SIB,unaffectedsiblingsofSCZpatients;PD,Parkinson’sdisease(OFF/ON
refer to l-DOPA treatment); AD, Alzheimer’s disease at mild dementia stage; FTD, frontotemporal dementia; aMCI, (clinical) amnestic mild cognitive impairment (i.e.,
prodromal AD); CTL, controls. M, male; F , female.
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of the task-relevant face feature (Figure 1). In each task, sub-
jects had to determine the expression or gender of each face using
a forced-choice paradigm. For the facial expression recognition
task, photographs of two female and two male faces depicting
basic emotions (happiness, fear, anger, and disgust) morphed
with a neutral face in 10% steps were randomly presented (the
duration varied slightly across studies, from 400ms to 1s). After
each face presentation, participants were asked to decide which
of ﬁve labels (happy, fearful, angry, disgusted, or neutral) best
described the presented facial expression using a forced-choice
paradigm. In the gender recognition task, photographs of the
faces of eight females and eight males morphed with an aver-
age face in 10% steps were randomly presented. Each face had a
neutralexpression.Aftereachfacepresentation,participantsindi-
cated the gender of the face using a forced-choice paradigm (man
or woman).
The duration of stimulus presentation varied across studies
(400 or 1000ms) and was always the same between the expression
and gender recognition tasks. Although expression and gender
morphs were performed using 10% steps, studies in patients with
SCZ and MDD revealed that using 20% steps yielded similar
results. Moreover, pilot testing revealed that increasing the stim-
ulus duration from 400ms to 1s did not affect the judgments
of these subjects but rather increased their conﬁdence in these
judgments, making the task less frustrating for them. We there-
fore used 20% steps and longer stimulus durations (1000ms) in
our studies comparing neurological patients to controls (i.e., AD,
FTD, aMCI, and PD). These patients, unlike SCZ, MDD, and SIB
patients, could not be transported to our experimental room and
were tested in their own hospitalization rooms.
STATISTICAL ANALYSIS
The face–emotion and gender recognition performances in each
group compared to the respective age- and sex-matched control
group are shown in Table 1. Detailed information about partic-
ipants and their performances have previously been published
(Bediou et al., 2005b, 2007a, 2009a; Lachenal-Chevallet et al.,
2006). In this study, we reanalyzed the data of these selected
studies using a statistical approach borrowed from meta-analysis.
However, given that we only focus on studies from our group,
a calculation of publication bias based on the Fail Safe N was
FIGURE1|F acial morphs used in the experiments.
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not appropriate. We thus invite cautious interpretation of our
results.
Intra-group comparisons were assessed using Cohen’s d effect
size measuring the percentage of variation in emotion and gender
recognition performances between groups as compared to their
own age- and sex-matched controls1. Cohen’s d is a standard-
ized, scale-free measure of the effect size of the mean difference
between two populations (Cohen, 1969). An effect size is exactly
equivalent to a “Z-score” of a standard normal distribution. As
suggested by Cohen (1969), an effect size of 0.2 could be consid-
ered to be small, 0.5 to be medium, and 0.8 to be large. An effect
size of −0.5 indicates that the mean of the patient group is 0.5
SDs below the mean of the control group. The effect size esti-
mate was corrected using a factor provided by Hedges and Olkin
(1985). Both the mean and the conﬁdence interval are important
in the interpretation of Cohen’s d; the mean corresponds to the
magnitude, whereas the conﬁdence interval reﬂects the signiﬁ-
cance of the difference. Importantly, the difference is statistically
signiﬁcant only if the conﬁdence interval does not include zero.
To more formally address the statistical signiﬁcance of between-
group differences, the calculation of Cohen’s d was followed by
a corrected two-tailed Student’s t-test for mean difference com-
parison between patients and the matched control group in each
situation.
1To increase statistical power, emotions, and morphing levels were collapsed.
Detailed statistical analyses including the morphing levels and emotions are avail-
able in corresponding papers, where emotion-speciﬁc deﬁcits are discussed more
thoroughly (see also Kohler et al., 2003).
Then, the inter-group differences were examined using a two-
tailed Student’s t-test for comparison of the mean differences
between groups of patients.
RESULTS
Gender recognition was preserved in all conditions as depicted
in Figure 2, which presents the standardized and bias-corrected
effect sizes as well as conﬁdence intervals for emotion and gen-
der recognition performance in each group. In contrast, emotion
recognition was impaired compared to controls in drug-naïve
ﬁrst-episode SCZ patients, before treatment onset [SCZ-OFF, d
corrected=−1.40 (−1.95; −0.86); p corrected<0.001] and after
theclinicalremissionofsymptoms[SCZ-ON,d corrected=−1.35
(−1.90; −0.80); p corrected<0.0001] using classical antipsy-
chotic treatment, in clinically remitted SCZ patients receiving
atypicalantipsychotictreatments[SCZ-rem.,d corrected=−0.81
(−1.41; −0.22); p corrected<0.01] as well as in SIB [d cor-
rected=−0.68 (−1.22; −0.14); p corrected=0.01]. PD patients
were also impaired relative to controls during either the OFF
phase [PD-OFF, d corrected=−1.54 (−2.41; −0.66); p cor-
rected<0.001] or the ON phase [PD-ON, d corrected=−1.56
(−2.44;−0.68);p corrected=0.03]of l-DOPAtreatment.Finally,
patients with AD [d corrected=−0.98 (−1.91; −0.05); p cor-
rected<0.001] and patients with FTD [d corrected=−2.54
(−3.71; −1.36); p corrected<0.0001] also exhibited a deﬁcit in
emotion recognition performance compared to controls. In con-
trast, subjects with aMCI [d corrected=−0.33 (−1.21; 0.55);
p corrected=0.4, ns] as well as patients with MDD [d cor-
rected=−0.42 (−1.05; 0.20); p corrected=0.2, ns] were not
impaired relative to their respective control groups.
FIGURE 2 | Corrected Cohen’s d effect sizes for facial expression (left)
and gender (right) recognition performances in each group compared to
its respective control group. (a) (Bediou et al., 2005b); (b) (Bediou et al.,
2007a); (c) (Bediou et al., 2009a); (d) (Lachenal-Chevallet et al., 2006).
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Concerning inter-group comparisons, we reported no dif-
ference in performance between the group composed of AD,
SIB, SCZ-rem, MDD, and aMCI patients. The performance of
this group was signiﬁcantly different from the performance of
a group comprising SCZ-OFF, SCZ-ON, PD–ON, and PD-OFF
(p =0.002)patients.Thislastgroupdifferedsigniﬁcantlyinterms
of the performance of FTD (p <0.0001).
DISCUSSION
This study aimed to compare emotion recognition deﬁcits over
differentneurologicalandpsychiatricconditionsthatinvolveearly
social behavioral disorders. Four groups of patients could be dis-
tinguished compared to their respective controls on the basis of
emotion recognition abilities as measured by Cohen’s d value:
(i) participants with MDD and aMCI did not present with any
signiﬁcant deﬁcit (d <0.5; ns); (ii) SCZ-rem and SIB as well as
AD patients presented with a mild impairment (0.5<d <1);
(iii) SCZ-OFF, SCZ-ON, PD-OFF and PD-ON patients pre-
sented with moderate impairment (1<d <2); and (iv) FTD
patients presented with a large impairment (d >2.5). Impor-
tantly, gender recognition did not differ from controls in any
of the groups, which suggests that the impairment is relatively
selective to the processing of emotional or social cues. These
results have implications for researchers who are interested in
the neurobiological processes involved in emotion perception and
recognition, and also for clinicians interested in the diagnosis
and treatment of pathologies associated with impairment in this
function.
As mentioned in the methods section, stimuli of longer dura-
tions were used in neurological patients to accommodate their
comfortlevels.Althoughpilottestingdidnotrevealanydifference
in performance and only increased conﬁdence in their judgments,
thereareimportantdifferencesbetweenthesetwotypesof presen-
tations.Whileastimulusthatis400msindurationmaydelveinto
the automatic processing of faces, the longer 1000-ms duration
may involve more elaborative and controlled processing of faces.
ThisviewissupportedbyEEGstudiesshowingthatearly(e.g.,P1,
N170)andlatecomponents(e.g.,P300,latepositivepotential)are
sensitive to different information in the face, including differen-
tial sensitivity to emotion (e.g., Krolak-Salmon et al., 2001, 2003,
2004,2006;forareview,seePourtoisandVuilleumier,2006;Eimer
and Holmes, 2007; Vuilleumier and Pourtois, 2007; Pourtois and
Vuilleumier, 2010).
IMPLICATIONS FOR THE NEUROBIOLOGICAL MECHANISMS OF
EMOTION PERCEPTION
Recent work has linked emotion recognition deﬁcits to the dis-
turbance of a frontotemporal brain network affected in a variety
of psychiatric and neurological conditions. In particular, sev-
eral structures in the temporal lobe (e.g., the amygdala and the
superior temporal sulcus) and in the frontal lobe (e.g., ventro-
medial frontal cortex) are thought to be either functionally or
structurally affected in SCZ (Aleman and Kahn, 2005; Bediou
et al., 2007b), in SIB (Lawrie et al., 1999), and at early stages
of AD (Braak and Braak, 1991) and FTD (Neary et al., 1998).
The basal ganglia, which are affected by PD, are also critical for
social message recognition (Curzon, 1977). In our study, the rel-
ative severity of the deﬁcit in each disease seems to be related to
the degree of functional or structural disturbance of these neural
networks.
Emotion recognition and frontotemporal neurodegeneration
TherelativedeclineinemotionrecognitionperformanceinaMCI,
AD, and FTD suggests a link between emotion recognition and
frontotemporal neurodegeneration. First, investigating emotion
recognition in aMCI and mild AD elucidates the impact of neu-
rodegenerative processes on speciﬁc neural systems, especially
the amygdala, which is critical for emotion perception (Adolphs
et al., 1994). In AD at the aMCI stage, neuroﬁbrillary tangles
mainly affect the rhinal cortex and the hippocampus, but lat-
eral temporal neocortical areas involved in emotion recognition,
such as the STS, are relatively spared. This phenomenon may
explain the preservation of this function at the aMCI stage and
the impairment at the mild dementia stage of AD. Indeed, at
this stage, neuroﬁbrillary tangles reach external temporal neo-
cortical regions including the STS (Braak and Braak, 1991), and
patients experience social disinvestment and lose their autonomy.
Thus,the evolution of emotion recognition abilities,which is pre-
served in aMCI and altered in mild AD, seems to coincide with
the progression of the neuropathology toward neocortical areas
and social withdrawal. Therefore, assessing emotion recognition
abilities may help in detecting this conversion at an even earlier
stage.
Second,the study of AD and FTD patients elucidates the addi-
tional impact of frontal neurodegeneration on emotion recogni-
tion.Prefrontalcortex“mirrorneurons,”whichdischargewhenan
individual performs an action and when he or she observes some-
one else performing the same action, may play an important role
in social cognition, especially for the recognition of facial expres-
sion(GalleseandRizzolatti,2004).FTDpatients,whopresentwith
structural lesions within these networks,exhibit greater deﬁcits in
social cognition in general (Lough et al., 2006) and in face pro-
cessing in particular (Keane et al.,2002),including the processing
of other socially relevant, changeable facial features such as gaze
direction (Bediou et al., 2009a). A greater deﬁcit in the frontal
variant compared to the temporal variant of FTD (Rosen et al.,
2004) further supports the critical role of the prefrontal cortex in
emotion recognition.
In our study, both the AD and the FTD groups displayed
deﬁcits in emotion recognition (relative to controls). We also
reported that FTD patients were impaired relative to AD patients
(p =0.002),who in turn tend to perform signiﬁcantly worse than
aMCI subjects (p =0.09), which provides indirect support for
a relationship between frontotemporal neurodegeneration and
emotion recognition deﬁcits (Bediou et al.,2009a;see also Lavenu
and Pasquier, 2005; Spoletini et al., 2008). Moreover, the fact that
gender recognition was preserved in all groups suggests that, on
the contrary, posterior cortical areas are not affected by any of
these disorders.
Emotion recognition and dopaminergic neurotransmission
The ﬁnding that emotion recognition is impaired to the same
extent in both SCZ and PD patients and is unaffected by anti- or
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pro-dopaminemedicationseemstoindicatethatemotionrecogni-
tiondeﬁcitsareindependentfromthedopaminergicsystem,which
tends to challenge the hypothesis of a link between dopaminer-
gic neurotransmission and emotion recognition (Salgado-Pineda
et al., 2005). This ﬁnding is, however, consistent with an inverted
U-Shape relationship between dopamine levels and emotion
recognition ability (Delaveau et al., 2005). Moreover, this ﬁnd-
ing also tells us that the deﬁcit is not speciﬁcally related to either
the mesocorticolimbic or the nigrostriatal pathways, which are
differentially affected by SCZ and PD.
Patients with SCZ present with functional and structural
deﬁcits affecting temporal structures including the amygdala and
STS and prefrontal regions involved in social cognition (Lawrie
and Abukmeil, 1998). These dysfunctions affecting the mesolim-
bicdopaminergicpathwaysresultinamoderateimpairmentinthe
frontotemporal processing of facial expressions in these patients
(Bediou et al., 2007b). The stability of facial expression recogni-
tion deﬁcits over the course of schizophrenia, its independence
with regard to treatment and the presence of a deﬁcit in unaf-
fected siblings suggest that impaired emotion recognition has
trait characteristics and may represent an intermediate pheno-
type or an endophenotype of schizophrenia. The amygdala has
been implicated in the pathophysiology of SCZ, including an
increased risk for SCZ (Aleman and Kahn, 2005). Amygdala dys-
functions may contribute to social cognition impairments, which
have been reported in both SCZ-rem patients and in SIB (Toomey
et al., 1999) and may be correlated with mild social disinvest-
ment. PD involves marked functional and structural abnormal-
ities in subcortical motor structures especially the basal gan-
glia and interconnected structures, including the amygdala and
the orbitofrontal cortex (Braak et al., 2003). Early dysfunction
of this network may be particularly critical for social message
recognition.
IMPLICATIONS FOR THE PATHOPHYSIOLOGY, DIAGNOSIS, AND
TREATMENT OF NEUROPSYCHIATRIC DISORDERS
Although the present results are based on a reanalysis of selected
studies from our group, in which we used the same methods
to investigate emotion and gender recognition abilities in var-
ious clinical and high-risk populations in comparison to age
and sex-matched control groups with limited sample sizes, our
transnosologic approach has potential clinical implications. First,
the ﬁnding that emotion recognition is differentially impaired
among individuals with similar behavioral, clinical, and social
disturbances (e.g., MDD vs. SIB) has potential implications for
early differential diagnosis and intervention. Second, the ﬁnd-
ing that emotion recognition is differentially impaired at dif-
ferent stages of the same chronological continua (e.g., aMCI
vs. AD) may help in the early diagnosis and planning of early
intervention.
Cognitive and social dysfunctions are common to a wide range
of disorders such that the clear diagnosis often remains challeng-
ing. For instance, a patient presenting with depressive symptoms
may cause the physician to suspect the ﬁrst symptoms of schiz-
ophrenia. Although social withdrawal is common to both disor-
ders, in our study, emotion recognition abilities were impaired
in SCZ and their SIB but not in MDD (Bediou et al., 2007a).
Hence, assessing facial emotion recognition (FER) abilities may
add valuable information in the differential diagnosis and initial
treatment of these disorders. Another example concerns the simi-
laritiesandthereforethedifﬁcultiesindifferentiatingbetweenSCZ
thatevolvestowarddementiaandFTDthatbeginswithbehavioral
disorderscompatiblewithSCZ(Kosmidisetal.,2008).FTDisalso
commonly misdiagnosed as bipolar disorder, given the overlap in
symptoms. Again, adding facial expression recognition and gaze
detection testing during the course of the differential diagnosis
may be beneﬁcial. No less challenging is the detection of the con-
version from the aMCI to mild dementia stage of AD, which may
be subtle and subjective. A precise evaluation of a putative social
dysfunction at that stage may be helpful in detecting social disin-
vestment and the progression toward a loss of autonomy (Bediou
et al.,2009a).
TheabsenceofsigniﬁcantemotionrecognitiondeﬁcitsinMDD
(and in aMCI, which is also known as prodromal AD) in our
study is consistent with the preserved structural and functional
integrity of the frontotemporal networks that are critical for
emotion processing. However, this ﬁnding conﬂicts with numer-
ous previous studies (Feinberg et al., 1986; Rubinow and Post,
1992; Persad and Polivy, 1993; Joormann and Gotlib, 2006; Joor-
mann et al., 2007; Yoon et al., 2009a,b). Beyond variations in the
methods, this discrepancy may reﬂect the heterogeneity of the
MDD population and may be due more speciﬁcally to differences
in patients’ characteristics (e.g., symptom severity, illness dura-
tion, medication status), which are known to impact the ability
to recognize emotions (Harmer et al., 2003, 2009;f o rar e v i e w
of emotion recognition in MDD, see Bediou et al., 2009b). For
instance, more severely depressed patients have displayed impair-
ment in the more complex social emotion recognition tasks (Lee
et al., 2005), whereas adolescents with bipolar disorders show
impairments in the recognition of emotion in the faces of chil-
dren but not adults (McClure et al., 2003). Moreover, MDD
patients are often socially isolated, but this may be a purely
behavioral consequence of the psychiatric disorder and not of
a functional impairment of neural networks involved in emotion
recognition.
CONCLUSION
In conclusion, emotion perception appears to be impaired in a
variety of neurological and psychiatric disorders, although with
different characteristics. In AD, the impairment seems to coin-
cide with the conversion toward dementia, whereas in SCZ, the
perception of emotion is impaired at very early stages and even
in unaffected siblings who are characterized by a genetic vul-
nerability to schizophrenia and have been found to share some
cognitiveimpairments(albeittoalesserextent)withtheiraffected
siblings. Hence, a deﬁcit in the ability to recognize certain emo-
tions may be a trait marker or an endophenotype of SCZ but a
state marker for AD. Taken together, these results have implica-
tions for researchers who are interested in the neurobiology of
emotion perception mechanisms and can offer clinicians the pos-
sibility of building bridges between neurological and psychiatric
disorders and to better understand the neurobiology (and time
course) of common behavioral disorders. Given the small sam-
ple sizes used in the present study,further studies involving larger
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groups of subjects are needed before we can appreciate the clin-
ical potential of such a transnosographic approach and add FER
tasks to existing diagnostic test batteries. Although preliminary,
thisstudyalsosuggeststhatanapproachbasedonoverallemotion
recognitionmaynotbesufﬁcientlysensitivetodisentangledeﬁcits
in face–emotion processing among: (a) psychosis, (b) mood dis-
orders, and (c) neurodegenerative diseases. Future meta-analyses
should address how face–emotion processing deﬁcits are unique
to the brain alterations in each of these populations.
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